Evaluation of a Lead NNMT Inhibitor in Humanized M

Description: The National Institutes of Health, Office of the Director intends to award a non-competitive, firm-fixed-price contract to evaluate a lead NNMT inhibitor in humanized M. This combined synopsis/solicitation is issued without competitive procedures, and the notice serves as the complete solicitation document without an additional written solicitation. Responses are due by August 19, 2026, and this is a federal procurement rather than a grant program.